SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-002969
Filing Date
2007-05-08
Accepted
2007-05-08 16:00:58
Documents
8
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. b65143ipe10vq.htm 10-Q 452152
2 EX-10.1 EMPLOYMENT LETTER DATED JANUARY 4, 2007, DOUGLAS L. MAYERS, M.D. b65143ipexv10w1.htm EX-10.1 46133
3 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b65143ipexv31w1.htm EX-31.1 7173
4 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b65143ipexv31w2.htm EX-31.2 7167
5 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b65143ipexv32w1.htm EX-32.1 3513
6 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b65143ipexv32w2.htm EX-32.2 3504
7 GRAPHIC b65143ipb6514301.gif GRAPHIC 3295
8 GRAPHIC b65143ipb6514302.gif GRAPHIC 776
  Complete submission text file 0000950135-07-002969.txt   527017
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 07828195
SIC: 2834 Pharmaceutical Preparations